Caregiver burnout is not only normal, but inevitable. A CHOP psychologist offers advice for struggling families.

This case study highlights a multimodal approach to surgical management of osteosarcomas in young children, maximizing control while providing a functional limb that will grow with the child.

Patrick J. Grohar, MD, PhD, focuses on developing therapies for a cancer that’s rare in adults but relatively common in the pediatric population.

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.

A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.

An unrelenting, deep bone pain that woke him up from sleep is what led to Jake’s diagnosis just last March of Ewing sarcoma, one of the most common bone tumors in children and adolescents.

The National Academy of Medicine elects two global leaders in cellular and gene therapy from Children’s Hospital of Philadelphia.

Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology, has been elected into the National Academy of Medicine (NAM).

The 17th Annual Parkway Run & Walk presented by Citadel raised a record-breaking $1.5 million to support childhood cancer research and care at Children’s Hospital of Philadelphia.

The CHAMP Lab at CHOP has created numerous 3D models to aide in the surgical care of patients with complex congenital anomalies and tumors.